Invesco Biotechnology & Genome ETF
PBE
PBE
68 hedge funds and large institutions have $56.9M invested in Invesco Biotechnology & Genome ETF in 2016 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 19 increasing their positions, 23 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
-5
Holders Change %
-6.85%
% of All Funds
1.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
19
Reduced
23
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
SAM
SignalPoint Asset Management
Springfield,
Missouri
|
$3.28M |
| 2 |
Citadel Advisors
Miami,
Florida
|
$2.13M |
| 3 |
Morgan Stanley
New York
|
$5.9M |
| 4 |
SG Americas Securities
New York
|
$1.07M |
| 5 |
UBS Group
Zurich,
Switzerland
|
$5.12M |
